Cisplatin, vinblastine, and hydrazine sulfate in advanced, non-small-cell lung cancer: a randomized placebo-controlled, double-blind phase III study of the Cancer and Leukemia Group B.

Abstract

This study suggests no benefit from the addition of hydrazine sulfate to an effective cytotoxic regimen.